810 likes | 2.17k Views
Management of Abdominal Tuberculosis Joint Hospital Surgical Grand Round. Dr Shirley Y.W. Liu Department of Surgery North District Hospital. • Tuberculosis in the Globe •. Pulmonary TB. Extrapulmonary TB. 87.5%. 10%. 2.5%. Abdominal tuberculosis (~11-16% of extrapulomnary TB).
E N D
Management of Abdominal TuberculosisJoint Hospital Surgical Grand Round Dr Shirley Y.W. Liu Department of Surgery North District Hospital
• Tuberculosis in the Globe • Pulmonary TB Extrapulmonary TB 87.5% 10% 2.5% Abdominal tuberculosis (~11-16% of extrapulomnary TB) Aston NO. World J Surg 1997;21:492-499 Singhal A, et al. Eur J Gastroenterol Hepatol 2005; 17:967-971
Tuberculosis • Incidence in Hong Kong (year 2005) • 90 new cases per 100 000 persons [http://www.info.gov.hk/dh/publicat/web/tb/tb2005e.htm] • Recent global resurgence of tuberculosis • HIV infection • Aging population • Widespread use of immunosuppresive agents [Horvath, et al. Am J Gastroenterol 1998;93:692-6] • Abdominal tuberculosis • Common surgical differential diagnosis in our daily practice
Abdominal tuberculosis • Epidemiology: • Both gender: equally affected • Most common age: 35-45 years [Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700] • Risk factors • Alcoholic liver disease • HIV infection • 9% of all new TB cases are related to HIV • Advanced age • Low socioeconomic status [Corbett, et al. Arch Intern Med 2003;163:1009-21]
Pathogenesis of abdominal TB Ingestion of contaminated milk products Hematogenous spread from pulmonary focus Mode of infection Direct spread from adjacent organs Swallowing of infected sputum
Abdominal tuberculosis Intestinal 49% Solid visceral 5% Peritoneal 42% Nodal 4% Khan R, et al. World J Gastroenterol 2006;12(39):6371-6375
1. Intestinal tuberculosis Small bowel & colon Ileocaecal region Niall O, et al. World J Surg 1997;21:492-499
1. Intestinal tuberculosis • Ulcerative type • Formation of mucosal ulcers • Bleeding • Perforation • Fistulation • Stricture • Hyperplastic type • Extensive inflammatory changes • Obstruction • Mass Aston NO. World J Surg 1997;21:492-499
2. Peritoneal Tuberculosis Acute form Chronic form Ascitic Clear straw-coloured ascitic fluid Fibrous Intestines and viscera matted together causing obstruction Encysted Matted intestines enclosing a loculation of serous fluid Purulent Purulent ascitic fluid Tuberculous peritonitis • Acute abdomen • Exploratory laparotomy • ascitic fluid • thickened omentum • scattered tubercles Ahmed ME, et al. Ann R coll Surg Engl 1994;76:75-79
3. Nodal/ Glandular tuberculosis • Less common • Enlargement of • Mesenteric lymph nodes • Retroperitoneal lymph nodes • Complications • Abscess formation
4. Solid visceral tuberculosis • Intraabdominal viscera: • Liver • Kidney • Spleen • Pancreas CT scan showing tuberculous nodules in liver and spleen USG showing tuberculous nodules in spleen
To start with… 24/ male Good past health • Complained of • Diffuse abdominal pain • Abdominal distension • Weight loss • Physical exam • Gross ascites • No peritonism or mass • Blood tests • All normal except elevated ESR 2 months
To start with… (Continued) • Plain X-ray • Normal • USG abdomen • Gross ascites only • CT abdomen • Gross ascites • Small bowel matted together in central abdomen • Enlarged mesenteric lymph nodes
To start with… (Continued) • Differential diagnosis • Abdominal tuberculosis • Malignancy • Lymphoma • Inflammatory disease
To diagnose abdominal tuberculosis… Concomitant PTB Clinical presentation Blood tests Tuberculin test Microbiology & histology Radiological test
Clinical presentation Acute form 41% Chronic form 50% Combined form 9% • Chronic pain • Ascites • Weight loss • Vomiting • Diarrhea • Fever • Mass • Peritonitis • Intestinal obstruction • Perforation • GI bleeding Leung VKS, et al. Hong Kong Med J 2006;12:264-271
Clinical Presentation Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700
Clinical Presentation • Non-specific symptoms & signs • High index of suspicion • More liberal use of investigations • Differential diagnosis • Malignancy • Lymphoma • Inflammatory bowel disease • Infective disease
Concomitant PTB • Concomitant PTB • Present in 15-25% only • Sputum smear and culture for AFB: • Low diagnostic yield • Abnormal CXR: • 19-83% • Average = 38% • Marshall JB, et al. Am J Gastroenterol 1993;88:989-999 • Horvath KD, et al. Am J Gastroenterol 1998;93:692-696 • Faylona JM, et al. Ann Coll Surg 1993;3:65-70
Blood tests • No specific diagnostic blood tests available • Common blood parameters: • Elevated ESR • Almost always raised but not exceed 60 mm/hr [Manohar, et al. Gut 1990;31:1130-2] • Mild anemia • normochromic/ normocytic [Marshall JB, et al. Am J Gastroenterol 1993;88:989-999] • Mild leukocytosis [Manohar, et al. Gut 1990;31:1130-2]
Tuberculin test • High specificity • Low sensitivity • Low positive predictive value 50-67% Huebner, et al. Clin Infect Dis 1993; 17:968-75
Radiological tests • No diagnostic feature available • Imaging guided peritoneal biopsy • Limited diagnostic sensitivity
USG abdomen Right lower quadrant mass consisting of matted bowel Ascites
Computer tomography scan Loculated ascites Gross ascites Thickened omentum Loculated ascites Tubercles in spleen & liver Thickened ileocaecal bowel Enlarged paraaortic LN
Contrast study • Good for intestinal tuberculosis affecting small or large bowel Stricture in descending colon Stricture in ileocaecal region
Microbiology and histology exam Definitive diagnosis: • 1950 Hoon, et al: • Ziehl-Neelsen stain for AFB • Tissue culture for mycobacteria • Caseating granulomas on histology • Hoon JR, et al. Int Abstr Surg 1950;91:417-40
Tissue Biopsy • Peritoneal tapping • Endoscopic biopsy • Laparoscopy • Laparotomy Histological exam Microbiological Smear & culture
Molecular Methods • Polymerase chain reaction (PCR) • PCR analysis for Mycobacterium tuberculosis complex in tissues • Reported as 100% sensitivity in some series Uzunkoy, et al. World J Gastroenterol 2004;10(24):3647-3549 Tzoanopoulos, et al. Eur J Intern Med 2003;14:367-371
Peritoneal tapping • Ziehl-Neelsen stain: 3% positive • At least 5000 bacteria/ ml is required • Culture for AFB: 35% positive • At least 10 bacteria is required • 66-83% positive if 1L of ascitic fluid is cultured after centrifugation Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700
Colonoscopy Mucosal nodules Mucosal ulceration Deformed Ileocaecal valve
Laparoscopy • Highest diagnostic yield • Macroscopic appearance 93% • Peritoneal biopsy for ZN stain 3-25% • Peritoneal biopsy for culture 38-92% • Histology 93% • Low complication rates Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700
Summary of diagnostic tests Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700
Retrospective review of abdominal TB in NDH • Method: • Retrospective review of medical records • Between January 2001 to December 2006 (six years inclusive) • With diagnosis of abdominal tuberculosis
Retrospective review of abdominal TB in NDH • 23 patients • Male: female = 11:12 • Median age = 48 (Range: 8 - 83) Histology or microbiology proven abdominal TB 13 patients Not proven 10 patients Suspected Abdominal TB 6 patients Other pathology 4 patients Peritoneal TB 53.8% Intestinal TB 46.2%
Total number of patients: 23 *Diagnosis confirmation by positive histology, smear or culture for AFB
Comparison of diagnostic sensitivity Sanai, et al. Aliment Pharmacol Ther 2005;22:685-700 Leung VKS, et al. Hong Kong Med J 2006;12:264-271
Treatment • Mainstay of treatment • Anti-tuberculous chemotherapy • Duration for 6-12 months • Response to treatment • Resolution of symptoms within 3 months of treatment
Role of Surgery • Indications of surgery • Diagnostic uncertainty • Diagnostic laparoscopy in particular • Complications • Obstruction • Perforation • Hemorrhage • Fistulation • Conservative surgical approach should be adopted
Conclusion • Remains a diagnostic challenge to surgeons • Vague and non-specific clinical features • Low yield of mycobacterium culture or smear • Invasive investigations are required for obtaining tissue for histopathology/ culture
Summary High index of suspicion More liberal use of invasive investigations Mainstay of treatment by anti-TB drugs